Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Otsuka
Pharma
Lilly, J&J launches top Clarivate's Drugs to Watch 2026 report
Two investigational cardiometabolic drugs from Eli Lilly stand out in Clarivate's annual Drugs to Watch report. J&J also has two drugs on the list.
Kevin Dunleavy
Jan 7, 2026 9:28am
FDA safety probe, Otsuka, ADC patent fight—Fierce Pharma Asia
Dec 5, 2025 8:45am
Otsuka wins FDA nod in ever-more-crowded kidney disease space
Nov 26, 2025 11:10am
Pfizer, Akeso, Lilly and more—Fierce Pharma Asia
Nov 14, 2025 8:50am
Fresenius, Sun, Teva and others launched drug recalls this fall
Nov 12, 2025 3:55pm
Lundbeck, Otsuka back survey on Alzheimer's agitation
Nov 12, 2025 12:07pm
